GC-MS Based Plasma Metabolomics for Identification of Candidate Biomarkers for Hepatocellular Carcinoma in Egyptian Cohort-Reference-Cited by-同舟云学术

GC-MS Based Plasma Metabolomics for Identification of Candidate Biomarkers for Hepatocellular Carcinoma in Egyptian Cohort

Published:2015-06-01 Issue:6 Volume:10 Page:e0127299
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Nezami Ranjbar Mohammad R.,Luo Yue,Di Poto Cristina,Varghese Rency S.,Ferrarini Alessia,Zhang Chi,Sarhan Naglaa I.,Soliman Hanan,Tadesse Mahlet G.,Ziada Dina H.,Roy Rabindra,Ressom Habtom W.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference45 articles.

1. Survival rate in patients with hepatocellular carcinoma: A retrospective analysis of 389 patients;TF Greten;Br J Cancer,2005

2. Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: Influence of HBsAg and anti-HCV status;F Trevisani;J Hepatol,2001

3. Test characteristics of alpha-fetoprotein for detecting hepatocellular carcinoma in patients with hepatitis C. A systematic review and critical analysis;S Gupta;Ann Intern Med,2003

4. Metabolomics-based search for therapeutic agents for non-alcoholic steatohepatitis;T Yoshihiko;Arch Biochem Biophys,2014

5. Fitian AI, Nelson DR, Liu C, Xu Y, Ararat M, Cabrera R. Integrated metabolomic profiling of hepatocellular carcinoma in hepatitis C cirrhosis through GC/MS and UPLC/MS‐MS. Liver International. 2014.

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ethanol-induced changes to the gut microbiome compromise the intestinal homeostasis: a review;Gut Microbes;2024-09-03

2. SLC13A3 is a major effector downstream of activated β-catenin in liver cancer pathogenesis;Nature Communications;2024-08-30

3. Branched-Chain Amino Acids in Liver Diseases: Complexity and Controversy;Nutrients;2024-06-14

4. Metabolomics reveals the implication of acetoacetate and ketogenic diet therapy in radioiodine-refractory differentiated thyroid carcinoma;The Oncologist;2024-05-18

5. Targeting metabolic reprogramming in hepatocellular carcinoma to overcome therapeutic resistance: A comprehensive review;Biomedicine & Pharmacotherapy;2024-01